Surgery for intracerebral hemorrhage: new evidence and changing perspectives - Report - MDSpire

Surgery for intracerebral hemorrhage: new evidence and changing perspectives

  • By

  • Airton Leonardo de Oliveira Manoel

  • Ali Msheik

  • Sophie Schuind

  • Ghaya Ibrahim K. Al Rumaihi

  • Fabio Taccone

  • December 1, 2025

  • 0 min

Share

Surgical Approaches to Intracerebral Hemorrhage: Emerging Evidence and Perspectives

Overview

Spontaneous intracerebral hemorrhage (ICH) remains a highly fatal stroke subtype with limited effective treatments. Recent trials of surgical interventions, including minimally invasive techniques and decompressive craniectomy, have yielded mixed results, highlighting challenges in improving functional outcomes despite advances in surgical methods.

Background

ICH accounts for a significant proportion of stroke-related mortality, with a 1-month fatality rate of 35–40%. Surgical evacuation of hematomas is theorized to reduce intracranial pressure, improve cerebral perfusion, and limit secondary brain injury caused by blood breakdown products. Traditional open craniotomy has been extensively studied but failed to demonstrate clear benefits over medical management in large randomized trials. Minimally invasive catheter-based approaches have been developed to reduce surgical morbidity, yet clinical trials have not shown significant improvements in functional outcomes or mortality. Recent trials such as ENRICH, MIND, and SWITCH have explored novel surgical techniques and patient selection to address these limitations.

Data Highlights

TrialInterventionPatient PopulationKey OutcomeResult
MISTIE IIIMinimally invasive surgery + thrombolysisSupratentorial ICH12-month functional independence45% vs 41% (p=0.33), no significant benefit
ENRICHMinimally invasive parafascicular evacuationLobar or anterior basal ganglia hemorrhagesEarly hematoma evacuation efficacyOngoing, designed to assess improved outcomes
SWITCHDecompressive craniectomy without hematoma evacuationSevere deep supratentorial ICHMortality and functional outcomesResults pending, exploring decompression role
MINDCatheter-based aspiration systemDeep and lobar ICHFunctional outcomesResults pending, testing distinct minimally invasive method

Key Findings

  • Open craniotomy has not demonstrated significant clinical benefit over medical management in large RCTs for supratentorial ICH.
  • High crossover rates and exclusion of comatose or herniating patients limit generalizability of prior surgical trials.
  • Minimally invasive catheter-based hematoma evacuation reduces clot volume substantially but has not improved functional independence or mortality in trials like MISTIE III.
  • The ENRICH trial employs a minimally invasive parafascicular approach aiming to preserve eloquent brain tissue and reduce surgical morbidity.
  • New trials (ENRICH, MIND, SWITCH) are investigating different surgical strategies and patient populations to clarify the role of surgery in ICH management.

Clinical Implications

Current evidence does not support routine early surgical evacuation of supratentorial ICH using traditional or minimally invasive methods to improve functional outcomes. Patient selection remains critical, particularly for those at risk of cerebral herniation or with large hematomas where surgery may be lifesaving. Emerging minimally invasive techniques that minimize brain injury show promise but require further validation in ongoing trials before widespread adoption.

Conclusion

Despite decades of research, surgical management of spontaneous ICH has yet to demonstrate clear functional benefits over medical therapy. Recent advances in minimally invasive techniques and ongoing trials may refine surgical indications and improve outcomes in selected patients.

References

  1. Hemphill et al. 2015 -- Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
  2. MISTIE III Trial Investigators 2019 -- Minimally Invasive Surgery with Thrombolysis in Intracerebral Hemorrhage Evacuation
  3. ENRICH Trial Investigators 2023 -- Early Minimally Invasive Removal of Intracerebral Hemorrhage
  4. SWITCH Trial Investigators 2023 -- Decompressive Craniectomy for Severe Deep Supratentorial ICH

Original Source(s)

Related Content